Fully-Functionalized Natural Product Probes to Expand the Chemical Tractability of the Human Proteome.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Angewandte Chemie

• Publication date

  2025-09-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/anie.202502648PMID 40937893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders.

  2024cited by this paper
• Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes.

  2024cited by this paper
• Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity

  2024cited by this paper
• Enhanced mapping of small-molecule binding sites in cells

  2024cited by this paper
• Chemical proteomic mapping of reversible small molecule binding sites in native systems.

  2024cited by this paper
• Ligand discovery by activity-based protein profiling.

  2024cited by this paper
• Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells

  2024cited by this paper
• Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells

  2024cited by this paper
• Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

  2024cited by this paper
• Chemical proteomic discovery of isotype-selective covalent inhibitors of the RNA Methyltransferase NSUN2.

  2023cited by this paper
• Proteome-Wide Fragment-Based Ligand and Target Discovery

  2023cited by this paper
• Activity-based protein profiling - finding general solutions to specific problems.

  2023cited by this paper
• Ribosome-rescuer PELO catalyzes the oligomeric assembly of NOD-like receptor family proteins via activating their ATPase enzymatic activity.

  2023cited by this paper
• DrugBank 6.0: the DrugBank Knowledgebase for 2024

  2023cited by this paper
• Synthesis of portimines reveals the basis of their anti-cancer activity

  2023cited by this paper
• Deubiquitinase-targeting chimeras for targeted protein stabilization

  2022cited by this paper
• canSAR: update to the cancer translational research and drug discovery knowledgebase

  2022cited by this paper
• Merits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors

  2022cited by this paper
• Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.

  2022cited by this paper
• Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies

  2022cited by this paper
• PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer

  2021cited by this paper
• Chemoproteomic-enabled phenotypic screening.

  2021cited by this paper
• A Chiral-Pool-Based Strategy to Access trans-syn-Fused Drimane Meroterpenoids: Chemoenzymatic Total Syntheses of Polysin, N-Acetyl-polyveoline and the Chrodrimanins.

  2021cited by this paper
• Natural products in drug discovery: advances and opportunities

  2021cited by this paper
• The Rise of Molecular Glues.

  2021cited by this paper
• Ring Distortion of Vincamine Leads to the Identification of Re-Engineered Antiplasmodial Agents

  2021cited by this paper
• Evaluation of fully-functionalized diazirine tags for chemical proteomic applications

  2021cited by this paper
• Late-Stage Diversification of Natural Products

  2020cited by this paper
• An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.

  2020cited by this paper
• Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

  2020cited by this paper
• Extraction of mRNA from Stalled Ribosomes by the Ski Complex.

  2020cited by this paper
• TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9

  2020cited by this paper
• Principle and design of pseudo-natural products

  2020cited by this paper
• Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.

  2020cited by this paper
• PhotoAffinity Bits: A photoaffinity-based fragment screening platform for efficient identification of protein ligands.

  2020cited by this paper
• PGRMC2 is an Intracellular Heme Chaperone Critical for Adipocyte Function

  2019cited by this paper
• Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs

  2019cited by this paper
• Histone methyltransferase SMYD2: ubiquitous regulator of disease

  2019cited by this paper
• Natural Products in the "Marketplace": Interfacing Synthesis and Biology.

  2019cited by this paper
• The Druggability of Solute Carriers.

  2019cited by this paper
• A chemical biology view of bioactive small molecules and a binder-based approach to connect biology to precision medicines

  2018cited by this paper
• Natural Product Total Synthesis: As Exciting as Ever and Here To Stay.

  2018cited by this paper
• Discovery of Modulators of Adipocyte Physiology Using Fully Functionalized Fragments.

  2018cited by this paper
• Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs.

  2018cited by this paper
• Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

  2018cited by this paper
• DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer’s Disease

  2018cited by this paper
• Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide

  2018cited by this paper
• Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs

  2017cited by this paper
• A Tryptoline Ring-Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine.

  2017cited by this paper
• Defining a Cancer Dependency Map.

  2017cited by this paper
• MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes

  2016cited by this paper
• Chemical proteomics approaches for identifying the cellular targets of natural products

  2016cited by this paper
• Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.

  2016cited by this paper
• Counting on natural products for drug design.

  2016cited by this paper
• Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.

  2016cited by this paper
• SLC transporters as therapeutic targets: emerging opportunities

  2015cited by this paper
• LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2

  2015cited by this paper
• The re-emergence of natural products for drug discovery in the genomics era

  2015cited by this paper
• Natural Products as Source of Therapeutics against Parasitic Diseases.

  2015cited by this paper
• A Call for Systematic Research on Solute Carriers.

  2015cited by this paper
• Cheminformatic comparison of approved drugs from natural product versus synthetic origins.

  2015cited by this paper
• PELO negatively regulates HER receptor signalling and metastasis

  2014cited by this paper
• Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human Cells

  2014cited by this paper
• Simultaneous structure–activity studies and arming of natural products by C–H amination reveal cellular targets of eupalmerin acetate

  2013cited by this paper
• Charting, navigating, and populating natural product chemical space for drug discovery.

  2012cited by this paper
• NCBI GEO: archive for functional genomics data sets—update

  2012cited by this paper
• A Historical Overview of Natural Products in Drug Discovery

  2012cited by this paper
• How chemoproteomics can enable drug discovery and development.

  2012cited by this paper
• mTOR signaling and drug development in cancer

  2010cited by this paper
• Natural products as chemical probes.

  2010cited by this paper
• Biomimetic syntheses of the neurotrophic natural products caryolanemagnolol and clovanemagnolol.

  2010cited by this paper
• On the potential of natural products in the discovery of pharma leads: a case for reassessment.

  2010cited by this paper
• Privileged scaffolds for library design and drug discovery.

  2010cited by this paper
• Impact of natural products on developing new anti-cancer agents.

  2009cited by this paper
• Escape from flatland: increasing saturation as an approach to improving clinical success.

  2009cited by this paper
• Natural products: chemical instruments to apprehend biological symphony.

  2008cited by this paper
• Cu-catalyzed azide-alkyne cycloaddition.

  2008cited by this paper
• Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries

  2008cited by this paper
• Human Misato regulates mitochondrial distribution and morphology.

  2007cited by this paper
• Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)—a general method for mapping sites of probe modification in proteomes

  2007cited by this paper
• The evolving role of natural products in drug discovery

  2005cited by this paper
• Natural products to drugs: natural product-derived compounds in clinical trials.

  2005cited by this paper
• Predicting protein druggability.

  2005cited by this paper
• The Renaissance of Natural Products as Drug Candidates

  2005cited by this paper
• Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery.

  2004cited by this paper
• Lessons from natural molecules

  2004cited by this paper
• Navigating chemical space for biology and medicine

  2004cited by this paper
• Natural products--a simple model to explain chemical diversity.

  2003cited by this paper
• A global representation of the protein fold space

  2003cited by this paper
• Otubains: a new family of cysteine proteases in the ubiquitin pathway

  2003cited by this paper
• Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides.

  2002cited by this paper
• Regulation of Stress-responsive Mitogen-activated Protein (MAP) Kinase Pathways by TAO2*

  2001cited by this paper
• Pairwise use of complexity-generating reactions in diversity-oriented organic synthesis.

  2000cited by this paper
• Target-oriented and diversity-oriented organic synthesis in drug discovery.

  2000cited by this paper
• Correlation of observed fold frequency with the occurrence of local structural motifs.

  1999cited by this paper
• Estimating the number of protein folds.

  1998cited by this paper
• A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

  1996cited by this paper
• RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.

  1994cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• Chemistry and biology of the immunophilins and their immunosuppressive ligands.

  1991cited by this paper

• No citing papers are available for this paper.